Treatment of Osteoporosis - TOP1 Clinical Study
NCT03901989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2019-04-03
Summary
This study investigates the effect of zeolite on bone mineral metabolism. The clinical parameters include bone mineral density, bone remodelling markers, fractures and fallings, the subjective evaluation of the overall health status and intensity of the musculoskeletal pain measured by VAS.
Conditions
Interventions
- DEVICE
-
zeolite
given for a period of 12 months
- DEVICE
-
cellulose
given for a period of 12 months
Sponsors & Collaborators
-
University of Rijeka
collaborator OTHER -
Polyclinic K-center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-14
- Primary Completion
- 2017-03-20
- Completion
- 2017-03-20
More Related Trials
-
Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031)
NCT00729183 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822)
NCT00863525 ·Status: COMPLETED ·Phase: PHASE1
-
Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid
NCT03812367 ·Status: WITHDRAWN
-
Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)
NCT00620113 ·Status: COMPLETED ·Phase: PHASE2
-
OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism
NCT01889134 ·Status: COMPLETED ·Phase: NA
-
A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)
NCT00112437 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Odanacatib (0822-059)
NCT01068262 ·Status: COMPLETED ·Phase: PHASE1
-
MAGnesium Effect With ANtiosteoporotic Drugs
NCT05328154 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Low Bone Density in Cystic Fibrosis.
NCT01812551 ·Status: COMPLETED ·Phase: PHASE3
-
Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans
NCT04313634 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-response Study With Strontium Malonate in Postmenopausal Women
NCT00409032 ·Status: COMPLETED ·Phase: PHASE2
-
Osteopenia and Renal Osteodystrophy: Evaluation and Management
NCT00108394 ·Status: COMPLETED ·Phase: PHASE4
-
Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women
NCT01159873 ·Status: TERMINATED ·Phase: PHASE1
-
Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer
NCT00213980 ·Status: COMPLETED ·Phase: PHASE2
-
Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)
NCT00533650 ·Status: COMPLETED ·Phase: PHASE2
-
Denosumab and Osteoporotic Vertebral Compression Fracture
NCT05058443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Oligopin Supplementation and Bone Turnover Markers and Antioxidant Changes in Postmenopausal Osteopenic Women
NCT03260803 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects
NCT04512872 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Efficacy and Safety of Amorphous Calcium Carbonate in RA Patient With Osteopenia or Osteoporosis
NCT05443360 ·Status: UNKNOWN ·Phase: NA
-
A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
NCT04757376 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
NCT00238745 ·Status: COMPLETED ·Phase: PHASE2
-
Bisphosphonates Effects On Alveolar Bone Among Osteoporotic Women
NCT02115490 ·Status: COMPLETED
-
A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®
NCT05405725 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-Ranging Study of MK-5442 in Postmenopausal Women With Osteoporosis (MK-5442-001)
NCT00960934 ·Status: TERMINATED ·Phase: PHASE2
-
Antiresorptive Effects of a 6-m Treatment Course With Ibandronate Plus Supplementation of Vitamine D and Calcium in Central America
NCT02635997 ·Status: COMPLETED